Windtree Therapeutics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company’s lead development product Aerosurf (lucinactant for inhalation), is an investigational combination drug/device product for the treatment of respiratory distress syndrome (RDS) in premature infants. Its technology platforms comprise a novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant, which is structurally similar to pulmonary surfactant, and proprietary drug delivery technologies for the delivery of aerosolized KL4 surfactant and other inhaled therapies. Windtree Therapeutics is headquartered in Warrington, Pennsylvania, the US.
Scope
- Detailed information on Windtree Therapeutics Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Windtree Therapeutics Inc in the form of a SWOT analysis
- An in-depth view of the business model of Windtree Therapeutics Inc including a breakdown and examination of key business segments
- News about Windtree Therapeutics Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Windtree Therapeutics Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Windtree Therapeutics Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Windtree Therapeutics Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
RespireRx Pharmaceuticals Inc
PARI Pharma GmbH
Ony Inc
Chiesi Farmaceutici SpA
AbbVie Inc
RespireRx Pharmaceuticals Inc
PARI Pharma GmbH
Ony Inc
Chiesi Farmaceutici SpA
AbbVie Inc
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Windtree Therapeutics Inc ...
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Windtree Therapeutics Inc - Key Facts 5
Windtree Therapeutics Inc - Key Employees 6
Windtree Therapeutics Inc - Key Employee Biographies 7
Windtree Therapeutics Inc - Major Products and Services 8
Windtree Therapeutics Inc - History 9
Windtree Therapeutics Inc - Company Statement 12
Windtree Therapeutics Inc - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Windtree Therapeutics Inc - Business Description 15
Windtree Therapeutics Inc - SWOT Analysis 16
SWOT Analysis - Overview 16
Windtree Therapeutics Inc - Strengths 16
Windtree Therapeutics Inc - Weaknesses 17
Windtree Therapeutics Inc - Opportunities 18
Windtree Therapeutics Inc - Threats 19
Windtree Therapeutics Inc - Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Windtree Therapeutics Inc, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Nov 14, 2017: Windtree Therapeutics Reports Third Quarter 2017 Financial Results 30
Aug 21, 2017: Windtree Therapeutics Reports Second Quarter 2017 Financial Results 32
May 15, 2017: Windtree Therapeutics Reports First Quarter 2017 Financial Results and Provides Key Business Updates 34
Mar 31, 2017: Windtree Therapeutics Reports Fourth Quarter 2016 Financial Results and Provides Key Business Updates 36
Section 6 – Appendix 38
Methodology 38
Ratio Definitions 38
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
List of Tables
Windtree Therapeutics Inc, Key Facts 5
Windtree Therapeutics Inc, Key Employees 6
Windtree Therapeutics Inc, Key Employee Biographies 7
Windtree Therapeutics Inc, ...
List of Tables
Windtree Therapeutics Inc, Key Facts 5
Windtree Therapeutics Inc, Key Employees 6
Windtree Therapeutics Inc, Key Employee Biographies 7
Windtree Therapeutics Inc, Major Products and Services 8
Windtree Therapeutics Inc, History 9
Windtree Therapeutics Inc, Other Locations 14
Windtree Therapeutics Inc, Subsidiaries 14
Windtree Therapeutics Inc, Key Competitors 20
Windtree Therapeutics Inc, Ratios based on current share price 21
Windtree Therapeutics Inc, Annual Ratios 22
Windtree Therapeutics Inc, Annual Ratios (Cont...1) 23
Windtree Therapeutics Inc, Interim Ratios 25
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Windtree Therapeutics Inc, Recent Deals Summary 29
Currency Codes 38
Capital Market Ratios 38
Equity Ratios 39
Profitability Ratios 39
Cost Ratios 40
Liquidity Ratios 40
Leverage Ratios 41
Efficiency Ratios 41
List of Figures
List of Figures
Windtree Therapeutics Inc, Performance Chart (2013 - 2017) 24
Windtree Therapeutics Inc, Ratio Charts 26
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals ...
List of Figures
Windtree Therapeutics Inc, Performance Chart (2013 - 2017) 24
Windtree Therapeutics Inc, Ratio Charts 26
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28